07/09/2021 |
SynAct Pharma AB |
Anders Dyhr Toft |
Other member of the company's administrative, management or supervisory body |
|
Acquisition |
SynAct |
Share |
SE0008241491 |
06/09/2021 |
5,648 |
Quantity |
104.20 |
SEK |
|
Notification
|
07/09/2021 |
SynAct Pharma AB |
Anders Dyhr Toft |
Other member of the company's administrative, management or supervisory body |
|
Acquisition |
SynAct |
Share |
SE0008241491 |
07/09/2021 |
1,300 |
Quantity |
102.57 |
SEK |
|
Notification
|
01/03/2021 |
SynAct Pharma AB |
Henrik Stage |
Chief Financial Officer (CFO) |
Yes |
Disposal |
SYNACT |
Share |
SE0008241491 |
24/02/2021 |
19,000 |
Quantity |
52.17605263 |
SEK |
|
Notification
|
01/03/2021 |
SynAct Pharma AB |
Henrik Stage |
Chief Financial Officer (CFO) |
Yes |
Disposal |
SYNACT |
Share |
SE0008241491 |
25/02/2021 |
22,725 |
Quantity |
50.4639736 |
SEK |
|
Notification
|
01/03/2021 |
SynAct Pharma AB |
Henrik Stage |
Chief Financial Officer (CFO) |
Yes |
Disposal |
SYNACT |
Share |
SE0008241491 |
26/02/2021 |
15,275 |
Quantity |
49.65069722 |
SEK |
|
Notification
|
23/02/2021 |
SynAct Pharma AB |
John Haurum |
Member of the Board of Directors |
Yes |
Disposal |
SYNACT |
Share |
SE0008241491 |
18/02/2021 |
5,968 |
Quantity |
55.0854 |
SEK |
|
Notification
|
11/01/2021 |
SynAct Pharma AB |
Thomas Jonassen |
Member of the Board of Directors, Other senior executive |
Yes |
Merger increase |
SynAct Pharma AB |
Share |
SE0008241491 |
06/01/2021 |
1,456,263 |
Quantity |
0.00 |
SEK |
History |
Notification
|
11/01/2021 |
SynAct Pharma AB |
Thomas Jonassen |
Member of the Board of Directors, Other senior executive |
Yes |
Merger increase |
SanAct PHarma AB |
Share |
SE0008241491 |
06/01/2021 |
1,456,263 |
Quantity |
0.00 |
SEK |
Revised |
Notification
|
11/01/2021 |
SynAct Pharma AB |
Thomas Jonassen |
Member of the Board of Directors, Other senior executive |
Yes |
Merger increase |
SynAct Pharma AB |
Share |
SE0008241491 |
06/01/2021 |
2,296,651 |
Quantity |
0.00 |
SEK |
|
Notification
|
11/01/2021 |
Synact Pharma AB |
Jeppe Øvli Øvlesen |
Chief Executive Officer (CEO)/Managing Directory |
Yes |
Merger decrease |
Synact Pharma AB |
Share |
SE0008241491 |
06/01/2021 |
1,456,263 |
Quantity |
0.00 |
SEK |
|
Notification
|